Security key
87583X109
Tango Therapeutics, Inc. - Common stock, par value $0.001 per share (TNGX)
CUSIP: 87583X109
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Total 13F shares
- 107,228,944
- Total 13F value
- $146,966,295
- Share change
- +796,981
- Put/Call ratio
- 0%
- SEC-reported price per share
- $1.37
- Number of holders
- 119
- Value change
- -$1,500,604
- Number of buys
- 55
- Number of sells
- 70
- Shares outstanding
- 162,373,380
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
119
Top holders
10
TNGX full security history
Ownership snapshot
Full 13F holder table
Tango Therapeutics, Inc. SEC filings
Tango Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TNGX - Tango Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TRV GP IV, LLC
Disclosed value leader
TRV GP IV, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
3/4/5
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
TRV GP IV, LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TRV GP IV, LLC's linked filing trail.
Comparable ownership
Top 5
TRV GP IV, LLC
10%
TCG Crossover Management, LLC
6.6%
EcoR1 Capital, LLC
6.5%
Boxer Capital Management, LLC
6.4%
Nextech Invest Ltd.
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TRV GP IV, LLC |
13F
Company
|
10%
|
$52,094,542
16,859,075 shares
|
— | 31 Dec 2024 |
| TCG Crossover Management, LLC |
13F
Company
|
6.6%
|
$33,174,240
10,736,000 shares
|
— | 31 Dec 2024 |
| EcoR1 Capital, LLC |
13F
3/4/5
Company · 10%+ Owner
|
6.5%
|
$32,848,974
10,630,736 shares
|
— | 31 Dec 2024 |
| Boxer Capital Management, LLC |
13F
3/4/5
Company · Other*
|
6.4%
|
$32,077,287
10,380,999 shares
|
— | 31 Dec 2024 |
| Nextech Invest Ltd. |
13F
Company
|
3.4%
|
$17,099,998
5,533,980 shares
|
— | 31 Dec 2024 |
| GILEAD SCIENCES, INC. |
13F
Company
|
3%
|
$15,000,229
4,854,443 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
119
Shares
107,228,944
Rows available
119
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
119
Q1 2025 holders
119
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|